Numaferm Revenue and Competitors
Estimated Revenue & Valuation
- Numaferm's estimated annual revenue is currently $2.4M per year.
- Numaferm's estimated revenue per employee is $130,667
Employee Data
- Numaferm has 18 Employees.
- Numaferm grew their employee count by -18% last year.
Numaferm's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | Scientist Downstream Processing & Analytics | Reveal Email/Phone |
5 | Associate Scientist | Reveal Email/Phone |
6 | Senior Scientist Downstream Processing & Analytics | Reveal Email/Phone |
7 | Senior Scientist | Reveal Email/Phone |
8 | BTA Downstream Processing & Analytics | Reveal Email/Phone |
Numaferm Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 13 | -24% | N/A | N/A |
#2 | $18.3M | 131 | 18% | N/A | N/A |
#3 | $1.6M | 24 | 41% | N/A | N/A |
#4 | $62.8M | 359 | 11% | N/A | N/A |
#5 | $5.2M | 42 | 0% | N/A | N/A |
#6 | $14M | 98 | 8% | N/A | N/A |
#7 | $18.8M | 134 | -20% | $70M | N/A |
#8 | $2.5M | 25 | 4% | N/A | N/A |
#9 | $0.9M | 11 | 10% | N/A | N/A |
#10 | $12.5M | 89 | 46% | N/A | N/A |
What Is Numaferm?
We believe that in the near future peptides have found their way into new markets and are a well-known feed stock for better products in life sciences and beyond. NUMAFERM supports you in these developments – from discovery to commercial production.
keywords:N/AN/A
Total Funding
18
Number of Employees
$2.4M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Numaferm News
2022-04-06 - The peptide therapeutics contract API manufacturing market is ...
... Philipp Burling (Chief Financial Officer, NUMAFERM). The research includes detailed profiles of key service providers (listed below)...
2022-03-22 - Peptide Therapeutics: Contract API Manufacturing Market ...
... NSJ Prayog Life Sciences; NUMAFERM; ONL Therapeutics; OPKO Health; Oramed Pharmaceuticals; ORPEGEN Peptide Chemicals; Oryn Therapeutics...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.4M | 18 | -5% | N/A |
#2 | $2M | 18 | -5% | N/A |
#3 | $2.1M | 20 | 0% | N/A |
#4 | $2.7M | 21 | 17% | N/A |
#5 | $4.2M | 22 | -29% | N/A |